Correlation Between Altamira Therapeutics and ESSA Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Altamira Therapeutics and ESSA Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Altamira Therapeutics and ESSA Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Altamira Therapeutics and ESSA Pharma, you can compare the effects of market volatilities on Altamira Therapeutics and ESSA Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Altamira Therapeutics with a short position of ESSA Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Altamira Therapeutics and ESSA Pharma.

Diversification Opportunities for Altamira Therapeutics and ESSA Pharma

0.61
  Correlation Coefficient

Poor diversification

The 3 months correlation between Altamira and ESSA is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Altamira Therapeutics and ESSA Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ESSA Pharma and Altamira Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Altamira Therapeutics are associated (or correlated) with ESSA Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ESSA Pharma has no effect on the direction of Altamira Therapeutics i.e., Altamira Therapeutics and ESSA Pharma go up and down completely randomly.

Pair Corralation between Altamira Therapeutics and ESSA Pharma

Given the investment horizon of 90 days Altamira Therapeutics is expected to generate 0.27 times more return on investment than ESSA Pharma. However, Altamira Therapeutics is 3.64 times less risky than ESSA Pharma. It trades about -0.14 of its potential returns per unit of risk. ESSA Pharma is currently generating about -0.14 per unit of risk. If you would invest  49.00  in Altamira Therapeutics on August 27, 2024 and sell it today you would lose (7.00) from holding Altamira Therapeutics or give up 14.29% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Altamira Therapeutics  vs.  ESSA Pharma

 Performance 
       Timeline  
Altamira Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Altamira Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
ESSA Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ESSA Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's forward indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Altamira Therapeutics and ESSA Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Altamira Therapeutics and ESSA Pharma

The main advantage of trading using opposite Altamira Therapeutics and ESSA Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Altamira Therapeutics position performs unexpectedly, ESSA Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ESSA Pharma will offset losses from the drop in ESSA Pharma's long position.
The idea behind Altamira Therapeutics and ESSA Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.

Other Complementary Tools

Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon